Jeffrey B. Landau - 16 Mar 2023 Form 4 Insider Report for CytomX Therapeutics, Inc. (CTMX)

Role
Chief Financial Officer
Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for Jeffrey B Landau
Issuer symbol
CTMX
Transactions as of
16 Mar 2023
Net transactions value
-$2,923
Form type
4
Filing time
20 Mar 2023, 18:43:29 UTC
Previous filing
06 Feb 2023
Next filing
22 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTMX Common Stock Sale $2,923 -1,477 -2.1% $1.98 69,248 16 Mar 2023 Direct F1, F2
holding CTMX Common Stock 4,500 16 Mar 2023 Fidelity Traditional IRA
holding CTMX Common Stock 3,180 16 Mar 2023 Schwab ROTH IRA
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units.
F2 Includes 52,205 restricted stock units.